Current status and prospects of GREM1 research in cancer (Review).

Zhu, Dantong; Zhao, Dong; Wang, Naixue; Cai, Fei; Jiang, Mingzhe; Zheng, Zhendong

Zhu, Dantong; Zhao, Dong; Wang, Naixue; Cai, Fei; Jiang, Mingzhe; Zheng, Zhendong.

Afiliação

Zhu D; Department of Medical Oncology, General Hospital of Northern Theater Command, Shenyang, Liaoning 110000, P.R. China.
Zhao D; Department of Medical Oncology, General Hospital of Northern Theater Command, Shenyang, Liaoning 110000, P.R. China.
Wang N; Department of Oncology, General Hospital of Northern Theater Command, Jinzhou Medical University, Shenyang, Liaoning 121017, P.R. China.
Cai F; Department of Oncology, General Hospital of Northern Theater Command, China Medical University, Shenyang, Liaoning 110000, P.R. China.
Jiang M; Department of Medical Oncology, General Hospital of Northern Theater Command, Shenyang, Liaoning 110000, P.R. China.
Zheng Z; Department of Medical Oncology, General Hospital of Northern Theater Command, Shenyang, Liaoning 110000, P.R. China.

Mol Clin Oncol ; 19(3): 69, 2023 Sep.

Article em En | MEDLINE | ID: mdl-37614374

Palavras-chave

bone morphogenetic protein antagonist; breast tumor; cancer; gremlin 1; pancreatic tumor; potential tumor targets; review

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Mol Clin Oncol Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google